Report Code: A12487 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the White Fungus Market
Request Now !White fungus is a fungal infection that occurs majorly among immunocompromised people, which includes COVID-19 positive patients, those with uncontrolled diabetes, people on a high dose of steroids, cancer, and AIDS. If the infection reaches the digestive tract, an individual can face difficulty in eating and swallowing food. If the infection is inside head or skull, the symptoms are headache and nausea. Some of the common symptoms are white patches on skin, white tongue, diarrhea, and hypoxia (low oxygen saturation levels), even after recovery from COVID-19.
It is not confirmed that which fungi is causing this disease; some of the doctors say that it is drug-resistant candidiasis. Spores of this fungus are present in the soil and air but it is noninfectious as our immunity suppresses the effect of fungi. Use of unhygienic mask and tap water used in humidifier attached to oxygen increases the spore accumulation in the body, which further gets worse due to suppressed immunity caused by the use of steroids in COVID-19 therapy. Major reason for spread of this infection is unknown and researchers are still working to find out the source of this disease.
COVID-19 Impact Analysis
Top Impacting Factors
Market Trends
Increase in prevalence of white fungus after recovery or during treatment of COVID-19 infections has prompted manufacturers to develop advanced and formulated medication for better clinical results.Center for Disease Control and Prevention (CDC) estimated that around 1.7 million people will be hospitalized for post COVID-19 complication. High prevalence of post COVID-19 complications is giving rise to new infections such as white fungus, which is propelling players to invest in R&D.
Manufacturers are focusing on advanced formulations with novel drug delivery systems such as nanotechnology. Use of advanced nanotechnology system for treatment in white fungus is emerging as one of the critical factors behind the growth of market.
Pfizer, Inc. is currently conducting clinical trials for determining the effectiveness, safety, and treatment patterns of Isavuconazole sulfate in the treatment of patients suffering from mucormycosis or invasive aspergillosis and white fungus. The trial is currently in Phase II and is expected to be completed by May 26, 2022.
Key Benefits of Report
Questions Answered in the White Fungus Market Report
White Fungus Market Report Highlights
Aspects | Details |
---|---|
By Drug Type |
|
By Route of Administration |
|
By End User |
|
By Region |
|
Key Market Players | Bayer Healthcare, Sigma-Aldrich Corporation, Sanofi-Aventis, Abbott Laboratories, Astellas Pharma Inc, Merck and Co. Inc., Glenmark Pharmaceuticals Ltd, GlaxoSmithKline, Pfizer Inc., Novartis |
Start reading.
This Report and over 66,944+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers